Serious adverse events during study follow-up
Rituximab group (n=13) | Placebo (n=3) |
Atypical thoracic pain (normal ECG) | Arterial occlusion right foot |
Elective total hip replacement for OA | Elective total hip replacement for OA |
Elective sigmoid resection after pre-existent recurring diverticulitis | Headache and concentration problems (neurological tests including MRI brain normal) |
Elective surgery for nephrolithiasis | |
Vertebral fracture after trauma | |
Elective herniated disc surgery | |
Elective knee arthroplasty for OA | |
Hospitalisation for COPD exacerbation (n=2) | |
Hospitalisation for depression | |
Thrombosis upper extremity; pulmonary embolism | |
STEMI caused by left main coronary artery stenosis | |
Pre-existent bladder atony |
COPD, chronic obstructive pulmonary disease; OA, osteoarthritis; STEMI, ST elevation myocardial infarction.